Pivotal role of PD-1/PD-L1 immune checkpoints in immune escape and cancer progression: Their interplay with platelets and FOXP3+Tregs related molecules, clinical implications and combinational potential with phytochemicals-Reference-Cited by-同舟云学术

Pivotal role of PD-1/PD-L1 immune checkpoints in immune escape and cancer progression: Their interplay with platelets and FOXP3+Tregs related molecules, clinical implications and combinational potential with phytochemicals

Published:2020-12 Issue: Volume: Page:
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Lee Dae Young^ORCID,Im Eunji,Yoon Dahye,Lee Young-Seob^ORCID,Kim Geum-Soog,Kim Donghwi^ORCID,Kim Sung-Hoon

Funder

Rural Development Administration

Publisher

Elsevier BV

Subject

Cancer Research

Reference298 articles.

1. PDL1 signals through conserved sequence motifs to overcome interferon-mediated cytotoxicity;Gato-Cañas;Cell Rep.,2017

2. PD-L1;Kythreotou;J. Clin. Pathol.,2018

3. Every step of the way: integrins in cancer progression and metastasis, Nature reviews;Hamidi;Cancer,2018

4. CD4(+) T cell help in cancer immunology and immunotherapy, Nature reviews;Borst;Immunology,2018

5. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review;Farhood;J. Cell. Physiol.,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape;Biomedicine & Pharmacotherapy;2024-02

2. Platelet-Based Nanoparticles with Stimuli-Responsive for Anti-Tumor Therapy;International Journal of Nanomedicine;2023-11

3. The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy;MedComm;2023-09-14

4. Induction of Cancer Cell Death by Apigenin: A Review on Different Cell Death Pathways;Mini-Reviews in Medicinal Chemistry;2023-08-09

5. Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab;Frontiers in Immunology;2023-08-09